Patient Name: Emily Thompson
Date of Service: 10/23/2024
Patient DOB: 07/14/1986
Appointment Time: 9:00 am – 9:45 am
Place of Service: Patient was located at their home at 123 Main St Anywhere US 12345
Provider was located at their office: 456 Storybook Ln Hollywood CA 96852
This session was provided via a HIPAA compliant interactive audio/video platform. The patient consented to this telemedicine encounter.
Subjective
Chief Complaint: Follow-up consultation for a 38-year-old Caucasian female experiencing a recurrence of symptoms related to chronic major depressive disorder (MDD).
HPI:
Ms. Thompson reports a worsening of depressive symptoms, including increased feelings of hopelessness, persistent fatigue, and decreased interest in previously enjoyable activities. She describes difficulty concentrating, anxiety and disruptions in sleep, with frequent awakenings throughout the night. Ms. Thompson expressed frustration with the impact of her symptoms on her functioning and relationships.
Objective
Allergies: No known drug allergies.
Substance Use Assessment: Denies use of tobacco, alcohol, or recreational drugs.
Exam: Vital signs within normal limits. Psychomotor retardation noted. Mood observed as consistently low throughout the examination.
MSE:
- Appearance: Appropriately dressed, appears stated age.
- Behavior: Psychomotor retardation observed.
- Speech: Normal rate, tone, and volume.
- Mood: Low throughout the session.
- Affect: Restricted.
- Thought Process: Logical and coherent.
- Thought Content: Fleeting thoughts of self-harm; no delusions or hallucinations.
- Cognition: Alert and oriented x3.
- Insight/Judgment: Good insight and sound judgment.
Assessment
Dx: F33.2 Major depressive disorder, recurrent severe without psychotic features
F41.3 Other mixed anxiety disorders
Plan
Medication Adjustments:
- Increase fluoxetine from 40 mg to 60 mg daily to address symptom exacerbation.
- Add quetiapine 25 mg at bedtime for mood stabilization and improved sleep.
Referral for Intensive Psychotherapy: Arrange bi-weekly CBT sessions focused on symptom management and relapse prevention.
Safety Monitoring: Implement a structured safety plan to address any emergent suicidal ideation or self-harm behaviors.
Follow-up and Next Steps: Schedule a follow-up appointment in two weeks to monitor treatment response and side effects.
Electronically signed by:
[Provider Name, Credentials, Date]
_____________________________________________________________________________________________
Rationale information is not required in your note; it is provided for educational purposes only.
Rationale and How the CPT Codes Were Selected (based on 2/3 elements):
- Number and Complexity of Problems Addressed: 2 Chronic illnesses: (MDD, recurrent) with exacerbation and Other mixed anxiety disorders
- Data Reviewed/Analyzed: None.
- Risk of Complications and/or Morbidity: Moderate (due to prescription drug management).
Rationale: The client displays Moderate number and complexity of problems with 2 chronic illnesses with exacerbation, No data reviewed, Moderate risk addressed by prescription drug management
CPT Code Selected: 99214